FDA approves rapid-acting inhaled insulin for children

Medical Xpress

FDA approves rapid-acting inhaled insulin for children

The U.S.

Food and Drug Administration has approved Afrezza (insulin human) Inhalation Powder for use in children and adolescents aged 6 years and older who are living with type 1 or type 2 diabetes. ...

전문 보기

이 뉴스, 독자들은 어떻게 느꼈나요?

첫 반응을 남겨보세요

로그인하면 감정 반응에 참여할 수 있어요.

FDA approves rapid-acting inhaled insulin for children

이 뉴스, 독자들은 어떻게 느꼈나요?

관련 뉴스

'science' 카테고리 뉴스

Traditional tertiary teaching models shortchanging neurodivergent students in health care studies

Jurassic viral gene may have helped apple snails start laying eggs on land

NASA-Funded Research Follows Bird Flight; Birds Follow Their Noses

Medical Xpress의 다른 기사

Faulty protein cleanup gene tied to severe early-onset neurological disorders

ADA: Once-weekly cagrilintide + semaglutide promising in type 2 diabetes

Researchers develop injectable device to control nerves without surgery